Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice

por Liu, Hongxia, Zhai, Jinguo, Wang, Bin, Fang, Maosheng
Publicado 2017

Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study

por Si, Tianmei, Zhang, Kerang, Tang, Jisheng, Fang, Maosheng, Li, Keqing, Zhuo, Jianmin, Feng, Yu
Publicado 2015

Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance

por Li, Huqun, Fang, Maosheng, Xu, Mingzhen, Li, Shihong, Du, Juan, Li, Weiyong, Chen, Hui
Publicado 2016

Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder

por Zhou, Yongjie, Cao, Zhongqiang, Yang, Mei, Xi, Xiaoyan, Guo, Yiyang, Fang, Maosheng, Cheng, Lijuan, Du, Yukai
Publicado 2017

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

por Jiang, Kaida, Li, Lingjiang, Wang, Xueyi, Fang, Maosheng, Shi, Jianfei, Cao, Qiuyun, He, Jincai, Wang, Jinan, Tan, Weihao, Hu, Cuili
Publicado 2017

Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance

por Li, Huqun, Peng, Shiyong, Li, Shihong, Liu, Shouqing, Lv, Yifan, Yang, Ni, Yu, Liangyu, Deng, Ya-Hui, Zhang, Zhongjian, Fang, Maosheng, Huo, Yunxiang, Chen, Ying, Sun, Taohua, Li, Weiyong
Publicado 2019

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

por He, Shen, Yu, Yimin, Huang, Jingjing, Yin, Jiahui, Niu, Yajuan, Lu, Yazhou, Wu, Bin, Fang, Maosheng, Wang, Xue, Tao, Zhiping, Li, Lehua, Li, Kan, Li, Yan, Ding, Xiujuan, Shen, Yifeng, Li, Huafang
Publicado 2023

Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis

por Wu, Xiaohui, Zhu, Yuncheng, Wu, Zhiguo, Huang, Jia, Cao, Lan, Wang, Yun, Su, Yousong, Liu, Hongmei, Fang, Maosheng, Yao, Zhijian, Wang, Zuowei, Wang, Fan, Wang, Yong, Peng, Daihui, Chen, Jun, Fang, Yiru
Publicado 2022

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China

por Li, Qian, Su, Yun’ai, Liao, Xuemei, Fang, Maosheng, Gao, Jianliang, Xu, Jia, Duan, Mingjun, Yu, Haiying, Yang, Yang, Chen, Zhiyu, Liu, Jintong, Yan, Shaoxiao, Yao, Peifen, Li, Shuying, Wang, Changhong, Wu, Bin, Zhang, Congpei, Si, Tianmei
Publicado 2023

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial

por Long, Yujun, Wu, Qiongqiong, Yang, Ye, Cai, Jingda, Xiao, Jingmei, Liu, Zhaoqian, Xu, Yifeng, Chen, Ying, Huang, Manli, Zhang, Ruiguo, Xu, Xijia, Hu, Jian, Liu, Zhifen, Liu, Fang, Zheng, Yingjun, Meng, Huaqing, Wang, Zhimin, Tang, Yanqing, Song, Xueqin, Chen, Yunchun, Wang, Xueyi, Liu, Tiebang, Wu, Xiaoli, Fang, Maosheng, Wan, Chunling, Zhao, Jingping, Wu, Renrong
Publicado 2023